in a meta-analysis of 19 randomized trials with over 1400 patients, the 24-hour decrease in blood pressure with hctz was inferior to angiotensin-converting enzyme inhibitors, angiotensin receptor blockers, beta-blockers, and calcium channel blockers (p <.001 for all).